KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

UiPath (PATH) Research & Development (2020 - 2026)

UiPath's Research & Development history spans 7 years, with the latest figure at $95.2 million for Q1 2026.

  • For Q1 2026, Research & Development fell 4.53% year-over-year to $95.2 million; the TTM value through Jan 2026 reached $385.2 million, up 1.19%, while the annual FY2026 figure was $385.2 million, 1.19% up from the prior year.
  • Research & Development reached $95.2 million in Q1 2026 per PATH's latest filing, down from $96.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $99.7 million in Q1 2025 to a low of $64.4 million in Q1 2022.
  • Average Research & Development over 5 years is $85.2 million, with a median of $85.6 million recorded in 2024.
  • The largest YoY upside for Research & Development was 120.63% in 2022 against a maximum downside of 26.17% in 2022.
  • A 5-year view of Research & Development shows it stood at $67.3 million in 2022, then increased by 25.5% to $84.5 million in 2023, then increased by 14.75% to $97.0 million in 2024, then decreased by 0.11% to $96.9 million in 2025, then decreased by 1.77% to $95.2 million in 2026.
  • Per Business Quant, the three most recent readings for PATH's Research & Development are $95.2 million (Q1 2026), $96.9 million (Q4 2025), and $98.3 million (Q3 2025).